City
Epaper

Delhi HC seeks Centre's response on plea seeking drugs' safety testing on vultures

By IANS | Updated: May 13, 2022 15:25 IST

New Delhi, May 13 The Delhi High Court on Friday sought the response of the Centre and others ...

Open in App

New Delhi, May 13 The Delhi High Court on Friday sought the response of the Centre and others on a plea seeking direction for safety testing of the drugs on wild scavenging birds, mainly vultures, before launching new NSAIDsNon-steroidal anti-inflammatory drugs in the open market.

The Public Interest Litigation (PIL) contended that NSAIDS like Aceclofenac, Nimesulide, Ketoprofen etc are harmful for Vultures, but no serious efforts and steps have been taken for their safety.

Issuing notice to the Ministry of Environment, Forests and Climate Change, Ministry of Health and Welfare, Central Drugs Standard Control Organization National Biodiversity Authority, Indian Veterinary Research Institute and Bombay Natural History Society, the division bench of Acting Chief Justice Vipin Sanghi and Justice Navin Chawla slated the matter for August 24.

As per the PIL, filed by petitioner Gaurav Kumar Bansal, it sought the respondents to check the toxicity of NSAIDs available in the market and if found toxic ban the manufacturing, distribution, retail formulation, injectable formulation and use of bolus of the same by way of evoking Section 26A of the Indian Drugs and Cosmetics Act.

Praying for directions from the court on the protection and conservation of the vultures in the country, the plea highlighted that they are listed as critically endangered by IUCN and also added in the Schedule -1 of the Indian Wildlife Protection Act - 1972 which is the highest category of the endangerment.

Notably, the population of three of the nine Indian species of vultures the white-rumped, the long-billed, and the slender-billed have crashed by 90 per cent in the mid-1990s. The birds are now listed as Critically Endangered by the IUCN, the highest threat category ahead of extinction.

To save them from certain extinction, the government of India's Action Plan for Vulture Conservation in India 2020-2025, which was presented to the Convention on Migratory Species (CMS) secretariat, advocates the prevention of misuse of veterinary non-steroidal anti-inflammatory drugs (NSAIDs) by ensuring their sale only on prescription.

As per reports, diclofenac, the drug widely used by veterinar as a painkiller is considered as the main cause of the dramatic 99 per cent vulture decline across Asia.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Vipin sanghiindiaNew DelhiDelhi High CourtNavin ChawlaPublic Interest LitigationDelhi delhi high courtThe new delhi municipal councilDelhi south-westIndiUk-india
Open in App

Related Stories

EntertainmentAjith Kumar Injured in Fan Frenzy After Padma Bhushan Award Ceremony, Actor Hospitalized In Chennai

MumbaiMumbai: Gold Sales Cross ₹12,000 Crores Nationwide on Akshaya Tritiya; Mumbai MMR Sees ₹800 Crores Trade

NationalAkshaya Tritiya 2025: Gold Market Sees Huge Footfall Despite Price Hike (Watch Video)

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

National Realted Stories

NationalKerala: 4 Dead After Smoke Fills Kozhikode Medical College, Probe Orders

NationalRename INC to Anti National Congress: BJP slams Cong after Channi questions surgical strike

NationalTN Health Department launches study on fatty liver disease among tribal communities

NationalTamil Nadu: Massive Fire Breaks at Warehouse in Karur

NationalDeepest condolences to all bereaved families: LoP Gandhi expresses grief over Goa stampede